Chula Vista, Calif.
The Düsseldorf, Germany-based Profil Institute for Metabolic Research is relocating its U.S. headquarters to 8,000-sf in Chula Vista, Calif. The facility is slated to open in October 2003 and will house administrative, research, and quality assurance operations. The Profil Institute is a clinical research organization that contracts with biotech and pharmaceutical firms to test experimental drugs for diabetes in metabolic disorders.
